1. Introduction
1.1. Market Definition & Scope
1.2. Market Ecosystem
1.3. Currency & Limitations
1.4. Key Stakeholders
2. Research Methodology
2.1. Research Approach
2.2. Process of Data Collection and Validation
2.2.1. Secondary Research
2.2.2. Primary Research/Interviews with Key Opinion Leaders of the Industry
2.3. Market Sizing and Forecasting
2.3.1. Market Size Estimation Approach
2.3.2. Growth Forecast Approach
2.3.3. Market Share Analysis
2.4. Assumptions for the Study
3. Executive Summary
4. Market Insights
4.1. Overview
4.2. Drivers
4.2.1. Increasing Approvals of Regenerative Medicine
4.2.2. Advances in Regenerative Medicine
4.2.3. Rising Incidences of Target Diseases
4.2.4. Increasing Funding for the Development of Regenerative Medicine
4.2.5. Increasing Applications of Regenerative Medicine in Newer Therapy Areas
4.3. Restraints
4.3.1. High Cost of Treatment
4.3.2. Ethical Issues Associated with Stem Cells
4.4. Opportunities
4.4.1. Rising Demand for Personalized Medicine
4.4.2 Rising Demand for Organ Transplants
4.4.3. Increasing Number of Products in the Pipeline
4.5. Challenges
4.5.1. Unfavorable Reimbursement Policies
4.5.2. Manufacturing Challenges
4.6. Factor Analysis
4.7. Trends
4.8. Regulatory Analysis
4.9. Porter’s Five Force Analysis
4.10. Investment & Funding Scenario
4.11. Pipeline Analysis
5. Regenerative Medicine Market Assessment—by Product
5.1. Overview
5.2. Gene Therapy
5.3. Cell Therapy
5.3.1. Stem Cell Therapy
5.3.1.1. Autologous Therapy
5.3.1.2. Allogenic Therapy
5.3.2. Platelet Rich Plasma Therapy
5.3.3. Cell-based Immunotherapy
5.3.3.1. CAR T Cell Therapy
5.3.3.2. Other Cell-based Immunotherapies
5.5. Tissue Engineering
6. Regenerative Medicine Market Assessment—by Application
6.1. Overview
6.2. Cardiovascular Diseases
6.3. Ophthalmic Diseases
6.4. Oncology
6.5. Neurological Diseases
6.6. Immunology & Inflammation
6.7. Musculoskeletal Diseases
6.8. Dermatological Diseases
6.9. Other Applications
7. Regenerative Medicine Market Assessment—by End User
7.1. Overview
7.2. Hospital & Clinics
7.3. Ambulatory Surgical Centers
8. Regenerative Medicine Market Assessment—by Geography
8.1. Overview
8.2. North America
8.2.1. U.S.
8.2.2. Canada
8.3. Europe
8.3.1. Germany
8.3.2. France
8.3.3. U.K.
8.3.4. Italy
8.3.5. Spain
8.3.6. Switzerland
8.3.7. Netherlands
8.3.8. Sweden
8.3.8. Rest of Europe (RoE)
8.4. Asia-Pacific
8.4.1. Japan
8.4.2. China
8.4.3. India
8.4.4. South Korea
8.4.5. Australia
8.4.6. Rest of Asia-Pacific (RoAPAC)
8.5. Latin America
8.5.1. Brazil
8.5.2. Mexico
8.5.3. Rest of Latin America (RoLATAM)
8.6. Middle East & Africa
9. Competition Analysis
9.1. Overview
9.2. Key Growth Strategies
9.3. Competitive Benchmarking
9.4. Competitive Dashboard
9.4.1. Industry Leaders
9.4.2. Market Differentiators
9.4.3. Vanguards
9.4.4. Emerging Companies
9.5. Market Ranking, by Key Players (2023)
10. Company Profiles (Company Overview, Financial Overview, Product Portfolio, Strategic Developments, and SWOT Analysis)
10.1. Novartis AG
10.2. Biogen Inc.
10.3. AstraZeneca plc
10.4. F. Hoffmann-La Roche AG
10.5. Integra Life Sciences
10.6. Sarepta Therapeutics, Inc.
10.7. Bayer AG
10.8. Amgen Inc.
10.9. CORESTEMCHEMON Inc.
10.10. Smith & Nephew plc
10.11. GSK plc
10.12. Takeda Pharmaceutical Company Limited
10.13. Astellas Pharma
10.14. Medtronic plc
10.15. AbbVie Inc.
10.16. Bristol Myers Squibb
10.17. Cook Group Incorporated
10.18. Pfizer Inc.
10.19. Merck KGaA
10.20. Vericel Corporation
(Note: SWOT Analysis Will be Provided for the Top 5 Companies.)
11. Appendix
11.1. Available Customization
11.2. Related Reports
List of Tables
Table 1 Global Regenerative Medicine Market, by Product, 2022–2031 (USD Million)
Table 2 Global Gene Therapy Market, by Country/Region, 2022–2031 (USD Million)
Table 3 Global Cell Therapy Market, by Type, 2022–2031 (USD Million)
Table 4 Global Cell Therapy Market, by Country/Region, 2022–2031 (USD Million)
Table 5 Global Stem Cell Therapy Market, by Type, 2022–2031 (USD Million)
Table 6 Global Stem Cell Therapy Market, by Country/Region, 2022–2031 (USD Million)
Table 7 Global Autologous Stem Cell Therapy Market, by Country/Region, 2022–2031 (USD Million)
Table 8 Global Allogenic Stem Cell Therapy Market, by Country/Region, 2022–2031 (USD Million)
Table 9 Global Platelet Rich Plasma Therapy Market, by Country/Region, 2022–2031 (USD Million)
Table 10 Global Cell-based Immunotherapy Market, by Type, 2022–2031 (USD Million)
Table 11 Global Cell-based Immunotherapy Market, by Country/Region, 2022–2031 (USD Million)
Table 12 Global CAR T Cell Therapy Market, by Country/Region, 2022–2031 (USD Million)
Table 13 Global Other Cell-based Immunotherapies Market, by Country/Region, 2022–2031 (USD Million)
Table 14 Global Tissue Engineering Market, by Country/Region, 2022–2031 (USD Million)
Table 15 Global Regenerative Medicine Market, by Application, 2022–2031 (USD Million)
Table 16 Global Regenerative Medicine Market for Cardiovascular Diseases, by Country/Region, 2022–2031 (USD Million)
Table 17 Global Regenerative Medicine Market for Ophthalmic Diseases, by Country/Region, 2022–2031 (USD Million)
Table 18 Global Regenerative Medicine Market for Oncology, by Country/Region, 2022–2031 (USD Million)
Table 19 Global Regenerative Medicine Market for Neurological Diseases, by Country/Region, 2022–2031 (USD Million)
Table 20 Global Regenerative Medicine Market for Immunology & Inflammation, by Country/Region, 2022–2031 (USD Million)
Table 21 Global Regenerative Medicine Market for Musculoskeletal Diseases, by Country/Region, 2022–2031 (USD Million)
Table 22 Global Regenerative Medicine Market for Dermatological Diseases, by Country/Region, 2022–2031 (USD Million)
Table 23 Global Regenerative Medicine Market for Other Applications, by Country/Region, 2022–2031 (USD Million)
Table 24 Global Regenerative Medicine Market, by End User, 2022–2031 (USD Million)
Table 25 Global Regenerative Medicine Market for Hospital & Clinics, by Country/Region, 2022–2031 (USD Million)
Table 26 Global Regenerative Medicine Market for Ambulatory Surgical Centers, by Country/Region, 2022–2031 (USD Million)
Table 27 Global Regenerative Medicine Market, by Country/Region, 2022–2031 (USD Million)
Table 28 North America: Regenerative Medicine Market, by Country, 2022–2031 (USD Million)
Table 29 North America: Regenerative Medicine Market, by Product, 2022–2031 (USD Million)
Table 30 North America: Stem Cell Therapy Market, by Type, 2022–2031 (USD Million)
Table 31 North America: Cell-based Immunotherapy Market, by Type, 2022–2031 (USD Million)
Table 32 North America: Regenerative Medicine Market, by Application, 2022–2031 (USD Million)
Table 33 North America: Regenerative Medicine Market, by End User, 2022–2031 (USD Million)
Table 34 U.S.: Regenerative Medicine Market, by Product, 2022–2031 (USD Million)
Table 35 U.S.: Stem Cell Therapy Market, by Type, 2022–2031 (USD Million)
Table 36 U.S.: Cell-based Immunotherapy Market, by Type, 2022–2031 (USD Million)
Table 37 U.S.: Regenerative Medicine Market, by Application, 2022–2031 (USD Million)
Table 38 U.S.: Regenerative Medicine Market, by End User, 2022–2031 (USD Million)
Table 39 Canada: Regenerative Medicine Market, by Product, 2022–2031 (USD Million)
Table 40 Canada: Stem Cell Therapy Market, by Type, 2022–2031 (USD Million)
Table 41 Canada: Cell-based Immunotherapy Market, by Type, 2022–2031 (USD Million)
Table 42 Canada: Regenerative Medicine Market, by Application, 2022–2031 (USD Million)
Table 43 Canada: Regenerative Medicine Market, by End User, 2022–2031 (USD Million)
Table 44 Europe: Regenerative Medicine Market, by Country/Region, 2022–2031 (USD Million)
Table 45 Europe: Regenerative Medicine Market, by Product, 2022–2031 (USD Million)
Table 46 Europe: Stem Cell Therapy Market, by Type, 2022–2031 (USD Million)
Table 47 Europe: Cell-based Immunotherapy Market, by Type, 2022–2031 (USD Million)
Table 48 Europe: Regenerative Medicine Market, by Application, 2022–2031 (USD Million)
Table 49 Europe: Regenerative Medicine Market, by End User, 2022–2031 (USD Million)
Table 50 Germany: Regenerative Medicine Market, by Product, 2022–2031 (USD Million)
Table 51 Germany: Stem Cell Therapy Market, by Type, 2022–2031 (USD Million)
Table 52 Germany: Cell-based Immunotherapy Market, by Type, 2022–2031 (USD Million)
Table 53 Germany: Regenerative Medicine Market, by Application, 2022–2031 (USD Million)
Table 54 Germany: Regenerative Medicine Market, by End User, 2022–2031 (USD Million)
Table 55 France: Regenerative Medicine Market, by Product, 2022–2031 (USD Million)
Table 56 France: Stem Cell Therapy Market, by Type, 2022–2031 (USD Million)
Table 57 France: Cell-based Immunotherapy Market, by Type, 2022–2031 (USD Million)
Table 58 France: Regenerative Medicine Market, by Application, 2022–2031 (USD Million)
Table 59 France: Regenerative Medicine Market, by End User, 2022–2031 (USD Million)
Table 60 U.K.: Regenerative Medicine Market, by Product, 2022–2031 (USD Million)
Table 61 U.K.: Stem Cell Therapy Market, by Type, 2022–2031 (USD Million)
Table 62 U.K.: Cell-based Immunotherapy Market, by Type, 2022–2031 (USD Million)
Table 63 U.K.: Regenerative Medicine Market, by Application, 2022–2031 (USD Million)
Table 64 U.K.: Regenerative Medicine Market, by End User, 2022–2031 (USD Million)
Table 65 Italy: Regenerative Medicine Market, by Product, 2022–2031 (USD Million)
Table 66 Italy: Stem Cell Therapy Market, by Type, 2022–2031 (USD Million)
Table 67 Italy: Cell-based Immunotherapy Market, by Type, 2022–2031 (USD Million)
Table 68 Italy: Regenerative Medicine Market, by Application, 2022–2031 (USD Million)
Table 69 Italy: Regenerative Medicine Market, by End User, 2022–2031 (USD Million)
Table 70 Spain: Regenerative Medicine Market, by Product, 2022–2031 (USD Million)
Table 71 Spain: Stem Cell Therapy Market, by Type, 2022–2031 (USD Million)
Table 72 Spain: Cell-based Immunotherapy Market, by Type, 2022–2031 (USD Million)
Table 73 Spain: Regenerative Medicine Market, by Application, 2022–2031 (USD Million)
Table 74 Spain: Regenerative Medicine Market, by End User, 2022–2031 (USD Million)
Table 75 Switzerland: Regenerative Medicine Market, by Product, 2022–2031 (USD Million)
Table 76 Switzerland: Stem Cell Therapy Market, by Type, 2022–2031 (USD Million)
Table 77 Switzerland: Cell-based Immunotherapy Market, by Type, 2022–2031 (USD Million)
Table 78 Switzerland: Regenerative Medicine Market, by Application, 2022–2031 (USD Million)
Table 79 Switzerland: Regenerative Medicine Market, by End User, 2022–2031 (USD Million)
Table 80 Netherlands: Regenerative Medicine Market, by Product, 2022–2031 (USD Million)
Table 81 Netherlands: Stem Cell Therapy Market, by Type, 2022–2031 (USD Million)
Table 82 Netherlands: Cell-based Immunotherapy Market, by Type, 2022–2031 (USD Million)
Table 83 Netherlands: Regenerative Medicine Market, by Application, 2022–2031 (USD Million)
Table 84 Netherlands: Regenerative Medicine Market, by End User, 2022–2031 (USD Million)
Table 85 Sweden: Regenerative Medicine Market, by Product, 2022–2031 (USD Million)
Table 86 Sweden: Stem Cell Therapy Market, by Type, 2022–2031 (USD Million)
Table 87 Sweden: Cell-based Immunotherapy Market, by Type, 2022–2031 (USD Million)
Table 88 Sweden: Regenerative Medicine Market, by Application, 2022–2031 (USD Million)
Table 89 Sweden: Regenerative Medicine Market, by End User, 2022–2031 (USD Million)
Table 90 Rest of Europe: Regenerative Medicine Market, by Product, 2022–2031 (USD Million)
Table 91 Rest of Europe: Stem Cell Therapy Market, by Type, 2022–2031 (USD Million)
Table 92 Rest of Europe: Cell-based Immunotherapy Market, by Type, 2022–2031 (USD Million)
Table 93 Rest of Europe: Regenerative Medicine Market, by Application, 2022–2031 (USD Million)
Table 94 Rest of Europe: Regenerative Medicine Market, by End User, 2022–2031 (USD Million)
Table 95 Asia-Pacific: Regenerative Medicine Market, by Country/Region, 2022–2031 (USD Million)
Table 96 Asia-Pacific: Regenerative Medicine Market, by Product, 2022–2031 (USD Million)
Table 97 Asia-Pacific: Stem Cell Therapy Market, by Type, 2022–2031 (USD Million)
Table 98 Asia-Pacific: Cell-based Immunotherapy Market, by Type, 2022–2031 (USD Million)
Table 99 Asia-Pacific: Regenerative Medicine Market, by Application, 2022–2031 (USD Million)
Table 100 Asia-Pacific: Regenerative Medicine Market, by End User, 2022–2031 (USD Million)
Table 101 China: Regenerative Medicine Market, by Product, 2022–2031 (USD Million)
Table 102 China: Stem Cell Therapy Market, by Type, 2022–2031 (USD Million)
Table 103 China: Cell-based Immunotherapy Market, by Type, 2022–2031 (USD Million)
Table 104 China: Regenerative Medicine Market, by Application, 2022–2031 (USD Million)
Table 105 China: Regenerative Medicine Market, by End User, 2022–2031 (USD Million)
Table 106 Japan: Regenerative Medicine Market, by Product, 2022–2031 (USD Million)
Table 107 Japan: Stem Cell Therapy Market, by Type, 2022–2031 (USD Million)
Table 108 Japan: Cell-based Immunotherapy Market, by Type, 2022–2031 (USD Million)
Table 109 Japan: Regenerative Medicine Market, by Application, 2022–2031 (USD Million)
Table 110 Japan: Regenerative Medicine Market, by End User, 2022–2031 (USD Million)
Table 111 India: Regenerative Medicine Market, by Product, 2022–2031 (USD Million)
Table 112 India: Stem Cell Therapy Market, by Type, 2022–2031 (USD Million)
Table 113 India: Cell-based Immunotherapy Market, by Type, 2022–2031 (USD Million)
Table 114 India: Regenerative Medicine Market, by Application, 2022–2031 (USD Million)
Table 115 India: Regenerative Medicine Market, by End User, 2022–2031 (USD Million)
Table 116 South Korea: Regenerative Medicine Market, by Product, 2022–2031 (USD Million)
Table 117 South Korea: Stem Cell Therapy Market, by Type, 2022–2031 (USD Million)
Table 118 South Korea: Cell-based Immunotherapy Market, by Type, 2022–2031 (USD Million)
Table 119 South Korea: Regenerative Medicine Market, by Application, 2022–2031 (USD Million)
Table 120 South Korea: Regenerative Medicine Market, by End User, 2022–2031 (USD Million)
Table 121 Australia: Regenerative Medicine Market, by Product, 2022–2031 (USD Million)
Table 122 Australia: Stem Cell Therapy Market, by Type, 2022–2031 (USD Million)
Table 123 Australia: Cell-based Immunotherapy Market, by Type, 2022–2031 (USD Million)
Table 124 Australia: Regenerative Medicine Market, by Application, 2022–2031 (USD Million)
Table 125 Australia: Regenerative Medicine Market, by End User, 2022–2031 (USD Million)
Table 126 Rest of Asia-Pacific: Regenerative Medicine Market, by Product, 2022–2031 (USD Million)
Table 127 Rest of Asia-Pacific: Stem Cell Therapy Market, by Type, 2022–2031 (USD Million)
Table 128 Rest of Asia-Pacific: Cell-based Immunotherapy Market, by Type, 2022–2031 (USD Million)
Table 129 Rest of Asia-Pacific: Regenerative Medicine Market, by Application, 2022–2031 (USD Million)
Table 130 Rest of Asia-Pacific: Regenerative Medicine Market, by End User, 2022–2031 (USD Million)
Table 131 Latin America: Regenerative Medicine Market, by Country/Region, 2022–2031 (USD Million)
Table 132 Latin America: Regenerative Medicine Market, by Product, 2022–2031 (USD Million)
Table 133 Latin America: Stem Cell Therapy Market, by Type, 2022–2031 (USD Million)
Table 134 Latin America: Cell-based Immunotherapy Market, by Type, 2022–2031 (USD Million)
Table 135 Latin America: Regenerative Medicine Market, by Application, 2022–2031 (USD Million)
Table 136 Latin America: Regenerative Medicine Market, by End User, 2022–2031 (USD Million)
Table 137 Brazil: Regenerative Medicine Market, by Product, 2022–2031 (USD Million)
Table 138 Brazil: Stem Cell Therapy Market, by Type, 2022–2031 (USD Million)
Table 139 Brazil: Cell-based Immunotherapy Market, by Type, 2022–2031 (USD Million)
Table 140 Brazil: Regenerative Medicine Market, by Application, 2022–2031 (USD Million)
Table 141 Brazil: Regenerative Medicine Market, by End User, 2022–2031 (USD Million)
Table 142 Mexico: Regenerative Medicine Market, by Product, 2022–2031 (USD Million)
Table 143 Mexico: Stem Cell Therapy Market, by Type, 2022–2031 (USD Million)
Table 144 Mexico: Cell-based Immunotherapy Market, by Type, 2022–2031 (USD Million)
Table 145 Mexico: Regenerative Medicine Market, by Application, 2022–2031 (USD Million)
Table 146 Mexico: Regenerative Medicine Market, by End User, 2022–2031 (USD Million)
Table 147 Rest of Latin America: Regenerative Medicine Market, by Product, 2022–2031 (USD Million)
Table 148 Rest of Latin America: Stem Cell Therapy Market, by Type, 2022–2031 (USD Million)
Table 149 Rest of Latin America: Cell-based Immunotherapy Market, by Type, 2022–2031 (USD Million)
Table 150 Rest of Latin America: Regenerative Medicine Market, by Application, 2022–2031 (USD Million)
Table 151 Rest of Latin America: Regenerative Medicine Market, by End User, 2022–2031 (USD Million)
Table 152 Middle East & Africa: Regenerative Medicine Market, by Product, 2022–2031 (USD Million)
Table 153 Middle East & Africa: Stem Cell Therapy Market, by Type, 2022–2031 (USD Million)
Table 154 Middle East & Africa: Cell-based Immunotherapy Market, by Type, 2022–2031 (USD Million)
Table 155 Middle East & Africa: Regenerative Medicine Market, by Application, 2022–2031 (USD Million)
Table 156 Middle East & Africa: Regenerative Medicine Market, by End User, 2022–2031 (USD Million)
Table 157 Recent Developments, by Company, 2020–2024
List of Figures
Figure 1 Research Process
Figure 2 Key Secondary Sources
Figure 3 Primary Research Techniques
Figure 4 Key Executives Interviewed
Figure 5 Breakdown of Primary Interviews (Supply Side & Demand Side)
Figure 6 Market Size Estimation
Figure 7 Global Regenerative Medicine Market, by Product, 2024 VS. 2031 (USD Million)
Figure 8 Global Regenerative Medicine Market, by Application, 2024 VS. 2031 (USD Million)
Figure 9 Global Regenerative Medicine Market, by End User, 2024 VS. 2031 (USD Million)
Figure 10 Global Regenerative Medicine Market, by Geography
Figure 11 Global Regenerative Medicine Market, by Product, 2024 VS. 2031 (USD Million)
Figure 12 Global Regenerative Medicine Market, by Application, 2024 VS. 2031 (USD Million)
Figure 13 Global Regenerative Medicine Market, by End User, 2024 VS. 2031 (USD Million)
Figure 14 Global Regenerative Medicine Market, by Geography, 2024 VS. 2031 (USD Million)
Figure 15 North America: Regenerative Medicine Market Snapshot
Figure 16 Europe: Regenerative Medicine Market Snapshot
Figure 17 Asia-Pacific: Regenerative Medicine Market Snapshot
Figure 18 Latin America: Regenerative Medicine Market Snapshot
Figure 19 Key Growth Strategies Adopted by Leading Players, 2020–2024
Figure 20 Global Regenerative Medicine Market: Competitive Benchmarking, by Product
Figure 21 Global Regenerative Medicine Market: Competitive Benchmarking, by Geography
Figure 22 Global Regenerative Medicine Market: Competitive Dashboard
Figure 23 Global Regenerative Medicine Market: Market Share Analysis/Market Ranking (2023)
Figure 24 Novartis AG: Financial Snapshot (2023)
Figure 25 Biogen Inc.: Financial Snapshot (2023)
Figure 26 AstraZeneca plc: Financial Snapshot (2023)
Figure 27 F. Hoffmann-La Roche AG: Financial Snapshot (2023)
Figure 28 Integra Life Sciences: Financial Snapshot (2023)
Figure 29 Sarepta Therapeutics, Inc.: Financial Snapshot (2023)
Figure 30 Bayer AG: Financial Snapshot (2023)
Figure 31 Amgen Inc.: Financial Snapshot (2023)
Figure 32 CORESTEMCHEMON Inc.: Financial Snapshot (2023)
Figure 33 Smith & Nephew plc: Financial Snapshot (2023)
Figure 34 GSK plc: Financial Snapshot (2023)
Figure 35 Takeda Pharmaceutical Company Limited: Financial Snapshot (2023)
Figure 36 Astellas Pharma: Financial Snapshot (2023)
Figure 37 Medtronic plc: Financial Snapshot (2023)
Figure 38 AbbVie Inc.: Financial Snapshot (2023)
Figure 39 Bristol Myers Squibb: Financial Snapshot (2023)
Figure 40 Cook Group Incorporated: Financial Snapshot (2023)
Figure 41 Pfizer Inc.: Financial Snapshot (2023)
Figure 42 Merck KGaA: Financial Snapshot (2023)
Figure 43 Vericel Corporation: Financial Snapshot (2023)